CD4 and Hodgkins lymphoma: Notably, PLWH on effective cART—with suppressed viral load and restored CD4+ T cell counts—still exhibit a ninefold higher risk of HL than HIV-negative individuals [104], further implicating IRIS and immune dysregulation as potential contributors to HIV-associated HL pathogenesis [103,105].